Csl

CSL is a global biotechnology company that specializes in developing and delivering innovative biotherapies and influenza vaccines. They generate revenue through the research, development, manufacturing, and marketing of products that treat serious and rare conditions, including immunodeficiency, bleeding disorders, and hereditary angioedema. Founded in 1916 in Australia, CSL has grown through strategic acquisitions and expansions, including the notable acquisition of Aventis Behring in 2004, which significantly bolstered their product portfolio and market presence.

Recent Posts by Csl

1-20 of 1392